Archives
|
Entry
|
Blogger
|
Date
▴
|
Xconomist
|
Location
|
|
SunEthanol Picks Up $25M, New Name; Infinity Pharma Pairs with Purdue Pharma; In-Q-Tel Taps Two Local Firms, & More Boston-Area Deals News
|
Rebecca Zacks |
11/24/08 |
|
Boston
|
|
Ironwood, Flush With Cash, Anticipates Big Year with Constipation Drug
|
Luke Timmerman |
11/21/08 |
|
Boston
|
|
Infinity Snags $75 Million Through Alliance with Purdue Pharma and Mundipharma
|
Luke Timmerman |
11/20/08 |
|
Boston
|
|
Aileron Develops New Class of Drugs To Go Where None Could Before
|
Luke Timmerman |
11/07/08 |
|
Boston
|
|
Aires Pharmaceuticals Emerges from Stealth Mode With Drug for Pulmonary Arterial Hypertension
|
Luke Timmerman |
11/05/08 |
|
San Diego
|
|
Anadys Drug Found Safe in Small Study, Aims to Contend in New Class of Hepatitis C Meds
|
Luke Timmerman |
11/01/08 |
|
San Diego
|
|
Novartis Option Fund Managing Director Says First Responsibility is to Portfolio Companies, Dislikes “Corporate VC” Moniker
|
Ryan McBride |
10/31/08 |
|
Boston
|
|
Vertex Cystic Fibrosis Drug Improves Breathing for 28 Days
|
Luke Timmerman |
10/20/08 |
|
Boston
|
|
Allozyne, Developer of Multiple Sclerosis Drug in Fewer Shots, Poised to Enter Clinical Trials
|
Luke Timmerman |
10/16/08 |
|
Seattle
|
|
Calistoga Builds Cancer Drug Strategy, Hires First CEO, Carol Gallagher
|
Luke Timmerman |
10/08/08 |
|
Seattle
|
|
The Boston-Area Obesity Treatment Cluster: Are Flood Gates Opening for Weight-Loss Drugs and Devices?
|
Ryan McBride |
10/08/08 |
|
Boston
|
|
Forma Buys SolMap Assets
|
Wade Roush |
10/02/08 |
|
Boston
|
|
Indevus Puts New Acromegaly Treatment Head-to-Head with Novartis Treatment in Phase 3 Trial
|
Ryan McBride |
09/30/08 |
|
Boston
|
|
New Biotech Biz Models (and the Tested Bob Langer-Terry McGuire Approach) Emerge at Xconomy Forum
|
Ryan McBride |
09/25/08 |
|
Boston
|
|
Xconomy Forum: A Big Thank You to Our Sponsors, Speakers, and Guests
|
Robert Buderi |
09/24/08 |
|
Boston
|
|
Millennium Enjoying New Era, Novartis Boosting Vaccine Effort, Living Proof Offering Frizz Fighters Online, & More Life Sciences News
|
Rebecca Zacks |
09/17/08 |
|
Boston
|
|
Gilead’s Seattle Crew Awaits FDA Clearance of Cystic Fibrosis Drug, Catalyst for Future Growth
|
Luke Timmerman |
09/15/08 |
|
Seattle
|
|
Novartis To Beef Up Vaccine Research in Cambridge
|
Luke Timmerman |
09/12/08 |
|
Boston
|
|
Millennium CEO Dunsire Juggles Growing Pipeline, Works to Maintain Nimble Culture—as New Owner Takeda Makes the Company its Center for Cancer Drug Development
|
Luke Timmerman |
09/10/08 |
|
Boston
|
|
Alnylam Adds Another RNA Approach, Vertex Tackles Hardest Hep C Cases, Zafgen Places Big Bet on Fat Shrinkers, & More Life Sciences News
|
Rebecca Zacks |
09/10/08 |
|
Boston
|
|
Zafgen, Developer of Fat-Shrinking Drugs, Hires Novartis Scientist as New CEO and Emerges From Stealth Mode
|
Luke Timmerman |
09/09/08 |
|
Boston
|
|
British Biotech Antisoma Sees Buyout of Xanthus as Beginning of U.S. Commercial Hub in Cambridge, MA
|
Ryan McBride |
09/08/08 |
|
Boston
|
|
Seattle Genetics’ Medical Point Man, Tom Reynolds, Aims to Capitalize on Hodgkin’s Drug
|
Luke Timmerman |
09/08/08 |
|
Seattle
|
|
Corporate Life Sciences VCs on the Rise in New England—the List
|
Ryan McBride |
09/03/08 |
|
Boston
|
|
Idera Receives Milestone Payment from Novartis For Asthma and Allergy Collaboration
|
Luke Timmerman |
09/02/08 |
|
Boston
|
|
Ariad Pharmaceuticals Edging Toward Becoming a Commercial Cancer Drug Company
|
Luke Timmerman |
09/02/08 |
|
Boston
|
|
After Cutting Deals With Most of the Big Drug Cos, Sermo CEO Offers Health 2.0 Survival Tip: You Will Not Pay Your Bills with “Ads by Google”
|
Ryan McBride |
08/28/08 |
|
Boston
|
|
Announcing Xconomy’s Next Forum: How to Build A Life Sciences Company
|
Robert Buderi |
08/25/08 |
|
Boston
|
|
ProteoStasis Takes Off From $45 Launch Pad, BitWave Receives $10M Transmission, GameLogic Reckons $8M Will Do, & More Deals News
|
Rebecca Zacks |
08/25/08 |
|
Boston
|
|
Vertex Marching Ahead With Cystic Fibrosis Program
|
Luke Timmerman |
08/01/08 |
|
Boston
|
|
Page 1 of
2 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2008 Xconomy. All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
